Maciel, G. et al. Hospitalisation rates among patients with primary Sjögren’s syndrome: a population-based study, 1995–2016. RMD Open 4, e000575 (2018).
Manzo, C., Martinez-Suarez, E., Kechida, M., Isetta, M. & Serra-Mestres, J. Cognitive function in primary Sjögren’s syndrome: A systematic review. Brain Sci. 9, 85 (2019).
Delalande, S. et al. Neurologic manifestations in primary Sjögren syndrome: A study of 82 patients. Medicine (Baltimore) 83, 280–291 (2004).
Morreale, M. et al. Neurological involvement in primary Sjögren syndrome: A focus on central nervous system. PLoS ONE 9, e84605 (2014).
Blanc, F. et al. Cognitive dysfunction and dementia in primary Sjögren’s syndrome. ISRN Neurol. 2013, 501327 (2013).
Koçer, B. et al. Cognition, depression, fatigue, and quality of life in primary Sjögren’s syndrome: Correlations. Brain Behav. 6, e00586 (2016).
Faurholt-Jepsen, M. et al. Patient-evaluated cognitive function measured with smartphones and the association with objective cognitive function, perceived stress, quality of life and function capacity in patients with bipolar disorder. Int. J. Bipolar Disord. 8, 31 (2020).
Gairy, K., Knight, C., Anthony, P. & Hoskin, B. Burden of illness among subgroups of patients with primary Sjögren’s syndrome and systemic involvement. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/keaa508 (2020).
Riega-Torres, J. C. L. et al. Cognitive dysfunction in Sjögren’s syndrome using the montreal cognitive assessment questionnaire and the automated neuropsychological assessment metrics: A cross-sectional study. Int. J. Rheum. Dis. 23, 1019–1023 (2020).
Tezcan, M. E. et al. Primary Sjögren’s syndrome is associated with significant cognitive dysfunction. Int. J. Rheum. Dis. 19, 981–988 (2016).
Albrecht, K. et al. Comorbidity and health care utilisation in persons with Sjögren’s syndrome: A claims data analysis. Clin. Exp. Rheumatol. 38(Suppl 126), 78–84 (2020).
Yeh, T.-C. et al. Risk of obstructive sleep apnea in patients with Sjögren syndrome and Behçet’s disease: A nationwide, population-based cohort study. Sleep Breath. 24, 1199–1205 (2020).
Shiboski, C. H. et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 76, 9–16 (2017).
Seror, R. et al. Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann. Rheum. Dis. 74, 859–866 (2015).
Poitrenaud, J., Eustache, F. & Agniel, A. Neuropsychologie Clinique des Démences : Evaluations et Prise en Charge (Solal, 1995).
Thomas-Anterion, C., Honore-Masson, S., Berne, G., Ruel, J. & Laurent, B. Le questionnaire de plainte cognitive (QPC) : Un outil de recherche de plainte suspecte d’évoquer une maladie d’Alzheimer. In L’année gérontologique, pp. 56–65 (2003).
Folstein, M. F., Folstein, S. E. & McHugh, P. R. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198 (1975).
Van der Linden, M. et al. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). in Vol. L’évaluation des Troubles de la Mémoire. Présentation de Quatre Tests de Mémoire Episodique (Avec Leur Etalonnage) (Marseille : Solal, 2004).
Wechsler, D. Wechsler Adults Intelligence Scale WAIS-III (Editions du Centre de Psychologie Appliquée, 2000).
Tombaugh, T. Trail making test A and B: Normative data stratified by age and education. Arch. Clin. Neuropsychol. 19, 203–214 (2004).
Berry, D., Allen, R. & Schmitt, F. Rey-Osterrieth complex figure: Psychometric characteristics in a geriatric sample. Clin. Neuropsychol. 5(2), 143–153 (1991).
Cardebat, D., Doyon, B., Puel, M., Goulet, P. & Joanette, Y. Formal and semantic lexical evocation in normal subjects performance and dynamics of production as a function of sex, age and educational level. Acta Neurol. Belg. 90, 207–217 (1990).
Stroop, J. Studies of interference in serial verbal reactions. J. Exp. Psychol. 18(6), 643–662 (1935).
Warrington, E. K. & Merle, J. The Visual Object and Space Perception Battery (Thames Valley Test Company, 1991).
Deloche, G. & Hannequin, D. Test de Dénomination Orale D’images. (les Editions du Centre de Psychologie Appliquée).
Peigneux, P. et al. A neuropsychological and functional brain imaging study of visuo-imitative apraxia. Rev. Neurol. (Paris) 156, 459–472 (2000).
Chalder, T. et al. Development of a fatigue scale. J. Psychosom. Res. 37, 147–153 (1993).
Schwarz, R., Krauss, O. & Hinz, A. Fatigue in the general population. Onkologie 26, 140–144 (2003).
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K. & Strohl, K. P. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann. Intern. Med. 131, 485–491 (1999).
Johns, M. W. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 14, 540–545 (1991).
Bastien, C. H., Vallières, A. & Morin, C. M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2, 297–307 (2001).
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatr. 4, 561–571 (1961).
Kosmadakis, C. S., Bungener, C., Pierson, A., Jouvent, R. & Widlöcher, D. Translation and validation of the revised social anhedonia scale (SAS Social Anhedonia Scale, M.L. Eckblad, L.J. Chapman et al., 1982). Study of the internal and concurrent validity in 126 normal subjects. Encephale 21, 437–443 (1995).
Gray-Little, B., Williams, V. & Hancock, T. An itemresponse theory analysis of the Rosenberg self-esteem scale. Personal. Soc. Psychol. Bull. 23(5), 443–451 (1997).
Spielberger, C. D. State-Trait Anxiety Inventory for Adults Sampler Set: Manual, Instrument and Scoring Guide (Mind Garden Inc, 1983).
Seeliger, T. et al. Cognitive impairment in patients with Neuro-Sjögren. Ann. Clin. Transl. Neurol. https://doi.org/10.1002/acn3.51123 (2020).
Yoshikawa, K. et al. Prevalence of Sjögren’s syndrome with dementia in a memory clinic. J. Neurol. Sci. 322, 217–221 (2012).
Liliang, P.-C. et al. Population-based study suggests an increased risk of Alzheimer’sdisease in Sjögren’s syndrome. Clin. Rheumatol. 37, 935–941 (2018).
Lin, T.-M. et al. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study. PLoS ONE 13, e0186475 (2018).
Goulabchand, R. et al. Hospitalization risks for neurological disorders in primary Sjögren’s syndrome patients. J. Clin. Med. 11, 1979 (2022).
Hou, T.-Y. et al. Higher risk of dementia in primary Sjogren’s syndrome. Ann. Clin. Transl. Neurol. 6, 633–641 (2019).
Pego-Reigosa, J. M., Restrepo Vélez, J., Baldini, C., Fernández, R.-F. & de Larrinoa, Í. Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Rheumatology (Oxford) 60, 2075–2084 (2021).
Manzo, C., Serra-Mestres, J. & Isetta, M. Comment on: Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Rheumatology https://doi.org/10.1093/rheumatology/keab602 (2021).
Segal, B. et al. Primary Sjögren’s Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 7, 46 (2009).
Liu, Z. et al. Health-related quality of life and psychological status of women with primary Sjögren’s syndrome: A cross-sectional study of 304 Chinese patients. Medicine (Baltimore) 96, e9208 (2017).
Cui, Y. et al. Anxiety and depression in primary Sjögren’s syndrome: a cross-sectional study. BMC Psychiatr. 18, 1–8 (2018).
Hsieh, M.-C., Hsu, C.-W., Lu, M.-C. & Koo, M. Increased risks of psychiatric disorders in patients with primary Sjögren’s syndrome-a secondary cohort analysis of nationwide, population-based health claim data. Clin. Rheumatol. 38, 3195–3203 (2019).
Azarfar, A., Ahmed, A. & Bég, S. Prevalence of anxiety, depression, sleep disturbance, fibromyalgia, obesity, and gastroesophageal disease in patients with rheumatic diseases. Curr. Rheumatol. Rev. https://doi.org/10.2174/1573397116666201211124815 (2020).
Segal, B. et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren’s syndrome. Arthritis Rheum. 59, 1780–1787 (2008).
Karageorgas, T. et al. Fatigue in primary Sjögren’s syndrome: Clinical, laboratory, psychometric, and biologic associations. Arthritis Care Res. (Hoboken) 68, 123–131 (2016).
Dardin, L. P. et al. Correlation of sleep quality with fatigue and disease activity among patients with primary Sjögren’s syndrome: A cross-sectional study. Sao Paulo Med. J. 138, 146–151 (2020).
Cui, Y. et al. Prevalence, correlates, and impact of sleep disturbance in Chinese patients with primary Sjögren’s syndrome. Int. J. Rheum. Dis. 23, 367–373 (2020).
Usmani, Z. A. et al. Sleep disordered breathing in patients with primary Sjögren’s syndrome: A group controlled study. Sleep Med. 13, 1066–1070 (2012).
Davies, K. et al. Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: A validation study. Rheumatol. Int. 39, 1867–1873 (2019).
Howard Tripp, N. et al. Fatigue in primary Sjögren’s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open 2, e000282 (2016).
Omdal, R., Mellgren, S. I. & Norheim, K. B. Pain and fatigue in primary Sjögren’s syndrome. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/kez027 (2019).
Mekinian, A. et al. Primary Sjögren’s syndrome: Central and peripheral nervous system involvements. Clin. Exp. Rheumatol. 38(Suppl 126), 103–109 (2020).
Fauchais, A.-L., Magy, L. & Vidal, E. Central and peripheral neurological complications of primary Sjögren’s syndrome. Presse Med. 41, e485-493 (2012).
de Oliveira, F. R. et al. Neurological and inflammatory manifestations in Sjögren’s syndrome: The role of the Kynurenine metabolic pathway. Int. J. Mol. Sci. 19, 3953 (2018).
Del Papa, N. et al. The role of interferons in the pathogenesis of Sjögren’s syndrome and future therapeutic perspectives. Biomolecules 11, 251 (2021).
Tjensvoll, A. B. et al. Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome. J. Neurol. https://doi.org/10.1007/s00415-020-10290-y (2020).
Zhang, X.-D. et al. Altered hippocampal functional connectivity in primary Sjögren syndrome: A resting-state fMRI study. Lupus 29, 446–454 (2020).
Lauvsnes, M. B. et al. Loss of cerebral white matter in primary Sjögren’s syndrome: A controlled volumetric magnetic resonance imaging study. Eur. J. Neurol. 21, 1324–1329 (2014).
Le Guern, V. et al. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a Case-control study. Ann. Rheum. Dis. 69, 132–137 (2010).
Miyamoto, S. T., Valim, V. & Fisher, B. A. Health-related quality of life and costs in Sjögren’s syndrome. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/key370 (2019).
Cornec, D. et al. Severe health-related quality of life impairment in active primary Sjögren’s syndrome and patient-reported outcomes: Data from a large therapeutic trial. Arthritis Care Res (Hoboken) 69, 528–535 (2017).
Cui, Y. et al. The impact of disease activity and psychological status on quality of life for Chinese patients with primary Sjögren’s syndrome. Patient Prefer. Adherence 12, 1513–1519 (2018).
Alunno, A. et al. Discrepancy between subjective symptoms, objective measures and disease activity indexes: The lesson of primary Sjögren’s syndrome. Clin. Exp. Rheumatol. 36(Suppl 112), 210–214 (2018).
Mæland, E., Miyamoto, S. T., Hammenfors, D., Valim, V. & Jonsson, M. V. Understanding fatigue in Sjögren’s syndrome: Outcome measures biomarkers and possible interventions. Front. Immunol. 12, 703079 (2021).
Bender, R. & Lange, S. Adjusting for multiple testing–when and how?. J. Clin. Epidemiol. 54, 343–349 (2001).
Segal, B. M., Rhodus, N., Moser Sivils, K. L. & Solid, C. A. Validation of the brief cognitive symptoms index in Sjögren syndrome. J. Rheumatol. 41, 2027–2033 (2014).
